Back
Inhibrx Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
61
INBX
Inhibrx
Last Price:
33.71
Seasonality Move:
22.62%
Sell
11
NBY
NovaBay Pharmaceuticals
Last Price:
0.09
Seasonality Move:
-10.02%
Buy
61
Inhibrx (INBX)
is a Buy
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $34.09. The Score for INBX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
INBX Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 35.19 | Sell |
| Chaikin Money Flow: | -53270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.42 - 35.06) | Sell |
| Bollinger Bands (100): | (30.56 - 38.4) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 29.5 | Sell |
| Chaikin Money Flow: | 117969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.12) | Sell |
| Bollinger Bands (100): | (0.1 - 0.22) | Sell |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.34 | Sell |
| 20-day SMA: | 34.67 | Sell |
| 50-day SMA: | 35.64 | Sell |
| 200-day SMA: | 27 | Buy |
| 8-day EMA: | 34.34 | Sell |
| 20-day EMA: | 34.65 | Sell |
| 50-day EMA: | 34.83 | Sell |
| 200-day EMA: | 29.77 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Sell |
| 20-day SMA: | 0.09 | Sell |
| 50-day SMA: | 0.12 | Sell |
| 200-day SMA: | 0.34 | Sell |
| 8-day EMA: | 0.08 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.12 | Sell |
| 200-day EMA: | 0.57 | Sell |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $0.10 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Inhibrx Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||